News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
1,497 Results
Type
Article (189)
Press Release (1308)
Section
Business (332)
Career Advice (1)
Deals (59)
Drug Delivery (3)
Drug Development (111)
FDA (70)
Job Trends (29)
News (579)
Policy (75)
Tag
Academia (4)
Alliances (147)
Alzheimer's disease (3)
Antibody-drug conjugate (ADC) (5)
Approvals (71)
Artificial intelligence (3)
Best Places to Work (20)
Biosimilars (49)
Breast cancer (1)
Cancer (11)
Cardiovascular disease (2)
Career advice (1)
Clinical research (95)
Collaboration (11)
COVID-19 (5)
C-suite (3)
Data (9)
Diagnostics (23)
Digital health (1)
Drug discovery (2)
Drug pricing (9)
Earnings (92)
Events (132)
Executive appointments (4)
FDA (76)
Funding (3)
GLP-1 (3)
Government (14)
Guidances (1)
Healthcare (48)
Immunology and inflammation (4)
Infectious disease (6)
Inflammatory bowel disease (1)
Inflation Reduction Act (2)
Intellectual property (2)
IPO (31)
IRA (2)
Job creations (9)
Job search strategy (1)
Layoffs (3)
Legal (19)
Lung cancer (3)
Manufacturing (13)
Medical device (45)
Medtech (45)
Mergers & acquisitions (31)
Metabolic disorders (1)
Multiple sclerosis (1)
Neuroscience (4)
NextGen: Class of 2026 (10)
Non-profit (2)
Obesity (1)
Opinion (3)
Pain (1)
Patents (3)
People (72)
Pharmacy benefit managers (2)
Phase 1 (31)
Phase 2 (38)
Phase 3 (42)
Pipeline (16)
Policy (5)
Postmarket research (4)
Preclinical (5)
Prostate cancer (1)
Radiopharmaceuticals (1)
Rare diseases (1)
Real estate (14)
Regulatory (53)
Research institute (4)
Series B (1)
Startups (8)
Supply chain (1)
The Weekly (1)
Vaccines (2)
Weight loss (1)
Date
Last 30 days (8)
Last 365 days (67)
2026 (11)
2025 (63)
2024 (117)
2023 (92)
2022 (212)
2021 (166)
2020 (161)
2019 (109)
2018 (112)
2017 (80)
2016 (87)
2015 (89)
2014 (42)
2013 (30)
2012 (30)
2011 (20)
2010 (14)
Location
Asia (412)
Australia (6)
California (14)
Canada (2)
China (3)
Delaware (1)
Europe (157)
Illinois (3)
Japan (4)
Maryland (3)
Massachusetts (2)
Minnesota (1)
Missouri (3)
New Jersey (4)
New York (1)
Northern California (8)
Southern California (5)
Texas (2)
United States (40)
Utah (1)
Washington D.C. (1)
Washington State (2)
Wisconsin (1)
1,497 Results for "samsung neurologica".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Samsung Biologics receives EcoVadis Platinum, the highest sustainability rating
January 28, 2026
·
3 min read
Press Releases
CEPI and Samsung Biologics collaborate to strengthen outbreak-ready vaccine production and global access
February 3, 2026
·
6 min read
Press Releases
Samsung Biologics reports fourth quarter and fiscal year 2025 financial results
January 21, 2026
·
5 min read
Press Releases
Samsung Epis Holdings Reports Fourth Quarter and Fiscal Year 2025 Financial Results
January 26, 2026
·
6 min read
Press Releases
Samsung Bioepis Announces Approval of Ustekinumab Biosimilar in Japan
December 23, 2025
·
2 min read
Press Releases
Samsung Bioepis Begins Commercialization of BYOOVIZ®, Biosimilar to Lucentis (Ranibizumab), in Europe
January 5, 2026
·
2 min read
Press Releases
Newly Established Samsung Epis Holdings to Drive Growth for Samsung Bioepis and a New Subsidiary
November 3, 2025
·
3 min read
Press Releases
Samsung Epis Holdings Delivers Business Updates at the 44th J.P. Morgan Healthcare Conference
January 15, 2026
·
5 min read
Press Releases
Samsung Bioepis Releases First Quarter 2026 US Biosimilar Market Report, Providing Updates to Evolving Drug Pricing Models
January 26, 2026
·
2 min read
Press Releases
Samsung Bioepis Announces Launch of Denosumab Biosimilars, OBODENCE™ and XBRYK™, in Europe
December 1, 2025
·
5 min read
1 of 150
Next
